Alia therapeutics

Cell & Gene Therapy

Facts

as of Nov 18, 2026

Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.

Headquarters
Milan, Italy
Employees
11-50estimated range

These are the key facts about Alia therapeutics on Alion as of Nov 18, 2026. Alia therapeutics is headquartered in Milan, Italy. The latest round is Seed of $4.8M, announced in 2023.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Milan ItalyHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$4.8MTotal raised
$350kPublic grants2 public grants
GrantLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
2024$156k1 record
2023$4.9M2 records
Largest rounds and grants
2023
$4.8M
2023
$195k
2024
$156k
Sources: funding announcements, grant and company registers

Money

Alia therapeutics has $4.8M paid in by investors, lenders and donors.

$4.8MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Grant
Jan 2024 · Grant
$156kPaid
Grant
Sep 2023 · Grant
$195kPaid
Equity raised · Sofinnova Partners
Apr 2023 · Seed
$4.8MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Owners & entities

Sources name Sofinnova Partners among the owners or investors of Alia therapeutics.

Named investors, no share stated1
Holders and shares as each register or filing states them.

Public record

Alia therapeutics: EUR 0–10,000 of EU lobbying in 2024.

Influence
EU lobbying, declared
EUR 0–10,000
Patents
Published US applications
3
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.

Milestones

Jan 1, 2024
Won a grant $156k · CORDIS
Sep 1, 2023
Won a grant $195k · CORDIS
Each milestone is dated by its source: registers, filings, the press